Nova will be at ESMO Congress 2026
ESMO Congress brings together clinicians, researchers, patient advocates and healthcare industry professionals from around the world to share the latest advances in oncology research, clinical practice and patient care.
Visit the ESMO Congress 2026 siteMeet our team
Two of us are on site. Book a slot ahead of time, or come find us during the congress.
Grégoire Boutonnet
Co-CEO & Chief Operating Officer
Co-CEO of Nova. Start here for partnerships, platform scoping, and how a Nova engagement works.
Book a meeting
Claudio Monteiro
Head of Content
Leads scientific content and communications. Find him for a walkthrough of the model library and our published evidence.
Book a meetingCome meet us to learn about our one of the latest work
We are presenting the work below on combining mechanistic disease models with statistical joint modeling to accelerate drug development and inform trial designs. Discover our work and connect with us at the congress.
Claudio MonteiroPredicting overall survival in EGFR-mutated aNSCLC via in silico clinical trials and hybrid joint modeling
A surrogate-assisted SAEM framework that brings population parameter inference within reach of stiff, high-dimensional QSP models.
View in the ESMO programOur poster from ESMO 2025
Modeling of pemetrexed maintenance de-escalation strategies using digital twins-based in silico clinical trials in FLAURA2 regimen as front-line treatment of metastatic EGFR-mutated non-small cell lung cancer
M. Duruisseaux, A. Nativel, P. Masson, N. Girard, J. Cadranel, A. Swalduz, M. Giaj Levra, H. Giraud, N. Goyard, S. Musilli, N. Ratto, J. Bosley, E. Pham, A. L'Hostis, C. Monteiro
Learn moreCannot make it to ESMO Congress 2026?
Book a call with our scientists and we will walk you through the same work, applied to your program.